Abstract
We explored solid solution formation between structurally highly similar active pharmaceutical
ingredients droperidol and benperidol in different crystal phases formed by these compounds. We
crystallized samples having different compound molar ratio to evaluate the solid solution
formation capabilities. Different crystallization conditions were used to evaluate solid solution
formation in different crystal phases, including nonsolvates, dihydrates, and several solvates. We
also explored the phase obtained in the desolvation of the obtained solvated products. Our results
clearly demonstrate that the formation of solid solutions strongly depends on the crystal structure,
as in part of the structures almost complete replacement of benperidol with droperidol was
achieved but in other structures the replacement was possible only up to a limited molar ratio.
Moreover, only limited replacement of droperidol with benperidol was achieved and only in part
of the structures. We investigated change of intramolecular and intermolecular energy introduced
by the molecule replacement using computational calculations. We show that experimentally we
obtained only structures where molecule replacement allows formation of efficient intermolecular
interactions, and energetic requirements of intermolecular interaction changes to obtain solid
solutions in nonsolvated phase are less strict than that for solvates.
Supplementary materials
Title
Supporting Information
Description
Additional data of crystallization experiments, solid form characterization, i.e., PXRD patterns,
DSC curves and 1H-NMR spectra of different composition samples, additional results and data
from comparison of crystal structures and calculation of pairwise intermolecular interaction energy
Actions